AI MARKET SCANNING

Lipocine Inc

AVG HISTORICAL GAP -0.50%
MAX GAP RECORD +6.59%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LPCN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN)
+0.95%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-2.06%
Mar 10, 2026 Earnings Release 2026-03-10 (BEFORE OPEN)
+0.89%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
+1.56%
Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
-1.82%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+1.87%
Mar 13, 2025 Earnings Release 2025-03-13 (BEFORE OPEN)
-3.12%
Nov 07, 2024 Earnings Release 2024-11-07 (BEFORE OPEN)
-0.99%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.1%
Bullish Gaps (3)
Bearish Gaps (7)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LPCN

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗